Therapy News and Research

RSS

Wearing a continuous positive airway pressure device helps heart failure patients with obstructive sleep apnea get a good night's rest

Wearing a continuous positive airway pressure (CPAP) device not only helps heart failure patients with obstructive sleep apnea get a good night's rest, it lowers blood pressure and heart rate well into the morning, apparently, by reducing sympathetic nervous system activity, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.

21 Jun 2005

Insulin resistance drug with anti-inflammatory effects reduces risk factors

A drug, which reduces insulin resistance and also may have anti-inflammatory and other effects on blood vessels, lowered cardiovascular risk factors in patients with diabetes more than another diabetes medicine, even though both drugs improved blood sugar control equally, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.

21 Jun 2005

Fish may help prevent heart failure as well as heart attacks

Older people who ate fish once or twice a week had a 20 percent lower risk of developing congestive heart failure during 12 years of follow-up, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.

21 Jun 2005

Pioneering new thyroid treatment

The doctor has developed a revolutionary technique for treating hyperthyroidism, also known as Graves' Disease. And earlier this month, Culham became the first person in North America to undergo the new procedure.

21 Jun 2005

Scientists identify inhibitors of the anthrax toxin

A collaborative team of scientists led by The Burnham Institute's Maurizio Pellecchia, Ph.D., has identified inhibitors of the anthrax toxin, termed lethal factor ("LF") that could be developed into an emergency treatment for exposure to inhalation anthrax.

21 Jun 2005

Breakthrough in understanding of children's brain development to help parents set kids on path to emotional, intellectual health

A major new research initiative at York University will build on new knowledge of the brain’s development, and help set children --including those with developmental disorders -- on the path towards emotional and intellectual health.

21 Jun 2005

WHO says AIDS fight will only be won with generic drugs

According to the World Health Organisation (WHO) the key to AIDS treatment in the developing world is generic drugs, but the target of 3 million people on therapy by the end of 2005 may now be unattainable.

21 Jun 2005

Vascular disease most common cause of male erectile dysfunction

A preeminent cardiologist reports, for the first time in a large prospective study, that certain of his patients with erectile dysfunction (ED) and heart problems can now safely use erection drugs that help up to 80% of men restore function and quality of life.

21 Jun 2005

New study finds many concerns with clinical trials

A new study led by OHRI Scientist and University of Ottawa Professor, Dr. Dean Fergusson, has looked at current practices in justifying the conduct of clinical trials and found many concerns. For starters, the report notes, some researchers don't even look at existing evidence, repeating trials that have already been conducted and scientifically validated.

21 Jun 2005

Motor skills: power for life

'Motor Magic', a program that works with pre-school children who are experiencing developmental difficulties, their parents and kindergarten staff, produces marked benefits in terms of motor skills and sensory processing, leading to improved self-confidence and concentration, and better engagement in learning activities.

21 Jun 2005

Confronting self-harm crisis in A&E departments

Health service staff have been told to 'own up' to widespread feelings of anger and disgust when faced with people who need medical treatment because they cut or harm themselves.

21 Jun 2005

Researchers use PET/CT for molecular imaging of the heart

For the first time, researchers used positron emission tomography (PET)/computed tomography (CT) for imaging the subcellar function of the heart - from its subcellular function to its morphologic appearance. The results of the study were reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

New discoveries in treatment for patients with non-Hodgkin's lymphoma

Three scientific studies - each highlighting new discoveries in treatment for patients with non-Hodgkin's lymphoma - were announced at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

PET might be a promising tool for early prediction of response to chemotherapy for ovarian can

Noninvasive positron emission tomography (PET) imaging may allow earlier prediction of a patient's response to chemotherapy for ovarian cancer, according to research reported at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

Cyr61 gene transfer appears potent in stimulation of myocardial angiogenesis

French scientists, examining the possibility of using nuclear medicine with gene therapy to fight heart diseases, reported their findings at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

Elevated C-reactive protein can foil diet's ability to lower cholesterol

If you have high levels of C-reactive protein (CRP), a marker in blood for inflammation that is strongly associated with heart disease, trying to lower your LDL-cholesterol through modest diet changes alone may not work.

20 Jun 2005

Thalidomide may be a potent anti-cancer treatment

When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment.

20 Jun 2005

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Researchers from the Johns Hopkins Bloomberg School of Public Health, Centers for Disease Control and Prevention and the Chiang Mai University in Thailand, evaluated the ability of inexpensive biological markers, which are obtainable in resource-poor countries, to determine which HIV-infected patients are in the greatest need of antiretroviral therapy.

20 Jun 2005

FDA severely limits access to cancer drug Iressa

After Food and Drug Administration (FDA) officials agreed with studies showing lung cancer drug, Iressa, did not help patients live longer, drug company AstraZeneca said it would severely limit access to its drug.

20 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

Monitoring and fine tuning the levels of the cancer drug topotecan in children with neuroblastoma holds promise for maximizing the drug's effectiveness while reducing its toxicity, according to investigators at St. Jude Children's Research Hospital.

19 Jun 2005